Immune monitoring for Lyme disease treatment
Part of Infections clinical trials.
This study looks at how your immune system responds to the bacteria that causes Lyme disease. It may help doctors better understand the disease and improve treatment. The trial includes people with a specific form of Lyme called acrodermatitis chronica atrophicans (a skin condition) and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed case of acrodermatitis chronica atrophicans (a skin condition caused by Lyme disease) or you are a healthy person with no history of Lyme disease
- You are willing to have a small skin sample taken under local anesthesia
- You are not pregnant or breastfeeding
- You do not have diabetes, immune system problems, or take immune-suppressing medications
- You have not taken antibiotics for Lyme disease for more than 18 months, or you have not been treated at all
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new blood test to help diagnose Lyme disease (borrelia infection) in children. If you are at the emergency room with symptoms that might be Lyme disease and you have a healthy immune system, you might be able to join.
This study looks at how foresters in Alsace are exposed to ticks and tick-borne diseases, and how to prevent them. The goal is to better protect forestry workers from these risks.
This study evaluates and treats people who currently have active Lyme disease, as defined by CDC criteria. It aims to provide expert care and follow-up while studying the disease.
This study looks at how a person’s immune system responds after exposure to Ixodes (black-legged) tick bites. It aims to better understand the body’s early immune reaction after tick exposure, using blood tests and small skin samples.
This research study examines why some people continue to have symptoms months after being treated for Lyme disease. Researchers will compare patients with ongoing symptoms to people who recovered well, to better understand what causes lasting problems and how to help.
This study is for people who have already received four doses of the Lyme vaccine (VLA15) in a previous study. It tests whether a fifth dose is safe and helps the body build more protection against Lyme disease.
Hear when a new Lyme Borreliosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.